Pump inhibitors primarily target ATP-binding cassette (ABC) transporters, which are responsible for the efflux of drugs from cancer cells. By inhibiting these transporters, pump inhibitors ensure that chemotherapy drugs remain inside the cancer cells for a longer duration, thereby increasing their cytotoxic effects. This can make previously resistant cancer cells more susceptible to treatment.
